also, go the the first part of the section dealing with these drugs and you will see that although reo requires a preapproval, it is pretty much sop. the only thing is that it must be administered by a physician familiar with the protocols used in the clinical trial setting and must be administered at a site which has performed such trials.
with those exceptions, it seems to be somewhat of a blanket approval for the use of reo in most cancers.